Sanofi Halts Amlitelimab Development, Marking Significant Setback in Blockbuster Ambitions and Raising Questions on OX40L Target
Sanofi, the global pharmaceutical giant, has officially ceased further development and pursuit of regulatory approval...
Knowledge and News for the Global Fight Against Cancer.
Sanofi, the global pharmaceutical giant, has officially ceased further development and pursuit of regulatory approval...
In a significant advancement for neuro-oncology, researchers at Oregon State University (OSU) have unveiled an...
A groundbreaking nationwide study has illuminated a deeply concerning bottleneck in the kidney transplant system,...
The Great Cycle Challenge (GCC) has officially entered its 12th year as a cornerstone of...
As the spring season marks a period of renewal and increased outdoor activity, a coalition...
From May 16 to 22, 2026, over 50 fellows and students converged at the prestigious...
Immune therapy has revolutionized cancer treatment, offering new hope to patients by harnessing the body’s...
A groundbreaking new study suggests that tailoring breast cancer screening to a woman’s individual risk...
The groundbreaking study, recently published in The Journal for ImmunoTherapy of Cancer, reveals that the...
The mechanism by which melanoma, one of the most aggressive and lethal forms of skin...